4.5 Article

COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID-19 in chronic lymphocytic leukaemia?

Carl Inge Edvard Smith et al.

Summary: The scarcity of plasmacytoid dendritic cells (pDCs) in patients with chronic lymphocytic leukaemia (CLL) may contribute to the severe clinical course of COVID-19 in these patients. Treatment of CLL with Bruton's tyrosine kinase (BTK) inhibitors can increase the number of pDCs.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2022)

Review Hematology

Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic

Petra Langerbeins et al.

Summary: The novel coronavirus, SARS-CoV-2, was first identified in Wuhan, China in December 2019, leading to a global pandemic. Cancer patients, especially those with chronic lymphocytic leukemia (CLL), are at higher risk for severe SARS-CoV-2 infections due to their impaired immune systems. Treatment initiation can further increase the risk of severe infections for CLL patients.

ACTA HAEMATOLOGICA (2021)

Article Oncology

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou et al.

Summary: Patients with CLL are more susceptible to the impact of COVID-19, with age, CLL-directed treatment, and cardiac failure being significant risk factors for outcomes. Untreated patients have a better chance of survival, and age, cardiac failure, and CLL-directed treatment are significant risk factors for OS.

LEUKEMIA (2021)

Article Medicine, General & Internal

Clinical Trends Among US Adults Hospitalized With COVID-19, March to December 2020 A Cross-Sectional Study

Shikha Garg et al.

Summary: The study described the clinical trends among adults hospitalized with COVID-19 in the United States from March to December 2020. It found that hospitalization, ICU admission, and death rates peaked in December, with older adults, males, and Hispanic or non-Hispanic Black individuals having the highest rates. Additionally, the frequency of intensive interventions for managing hospitalized patients decreased over time.

ANNALS OF INTERNAL MEDICINE (2021)

Review Medicine, General & Internal

Systemic corticosteroids for the treatment of COVID-19

Carina Wagner et al.

Summary: Systemic corticosteroids may slightly reduce all-cause mortality in people with COVID-19, with low-certainty evidence on outcomes like ventilator-free days. More high-quality studies are needed to determine treatment effects.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

Editorial Material Medicine, General & Internal

A novel coronavirus outbreak of global health concern

Chen Wang et al.

LANCET (2020)

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Public, Environmental & Occupational Health

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

Andrew T. Levin et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)

Article Pharmacology & Pharmacy

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries

Krzysztof Piotr Malinowski et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Geriatrics & Gerontology

A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients

Fabio Salvi et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)

Review Oncology

Infectious complications of chronic lymphocytic leukemia

PD Wadhwa et al.

SEMINARS IN ONCOLOGY (2006)